Low-level laser therapy alleviates neuropathic pain and promotes function recovery in rats with chronic constriction injury: Possible involvements in hypoxia-inducible factor 1α (HIF-1α)

Journal of Comparative Neurology

Volumn 520, Issue 13, 2012, Pages 2903-2916

  Hsieh, Yueh Ling ^a   Chou, Li Wei ^a,b   Chang, Pei Lin ^a   Yang, Chen Chia ^c   Kao, Mu Jung ^d   Hong, Chang Zern ^e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Chronic constrictive injury; Functional recovery; Hypoxia inducible factor 1 ; Low level laser therapy; Neuropathic pain

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; PROTEIN S 100; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CHRONIC CONSTRICTION INJURY; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; IMMUNOASSAY; IRRADIATION; LOW LEVEL LASER THERAPY; MALE; NERVE FUNCTION; NEUROPATHIC PAIN; NONHUMAN; OUTCOME ASSESSMENT; PERIPHERAL NERVE INJURY; PERONEUS NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RADIATION DOSE; RAT; SCIATIC NERVE INJURY; SHAM PROCEDURE; THERAPY EFFECT; TIBIAL NERVE;

ANIMALS; BLOTTING, WESTERN; CONSTRICTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LASER THERAPY, LOW-LEVEL; MALE; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SCIATIC NERVE;

EID: 84863598560     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23072     Document Type: Article

References (44)

1. Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H, Verma A. 2003. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 162: 1789-1806.
2. Albertini R, Villaverde AB, Aimbire F, Salgado MA, Bjordal JM, Alves LP, Munin E, Costa MS. 2007. Anti-inflammatory effects of low-level laser therapy (LLLT) with two different red wavelengths (660 nm and 684 nm) in carrageenan-induced rat paw edema. J Photochem Photobiol B 89: 50-55.
3. Albertini R, Villaverde AB, Aimbire F, Bjordal J, Brugnera A, Mittmann J, Silva JA, Costa M. 2008. Cytokine mRNA expression is decreased in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low-level laser therapy. Photomed Laser Surg 26: 19-24.
4. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA. 1994. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 634: 7-12.
5. Bain JR, Mackinnon SE, Hunter DA. 1989. Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plast Reconstr Surg 83: 129-138.
6. Barbe MF, Barr AE, Gorzelany I, Amin M, Gaughan JP, Safadi FF. 2003. Chronic repetitive reaching and grasping results in decreased motor performance and widespread tissue responses in a rat model of MSD. J Orthop Res 21: 167-176.
7. Barbosa RI, Marcolino AM, de Jesus Guirro RR, Mazzer N, Barbieri CH, de Cassia Registro Fonseca M. 2010. Comparative effects of wavelengths of low-power laser in regeneration of sciatic nerve in rats following crushing lesion. Lasers Med Sci 25: 423-430.
8. Baron R. 2000. Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain 16: S12-S20.
9. Bennett GJ, Xie YK. 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
10. Bertolini GR, Artifon EL, Silva TS, Cunha DM, Vigo PR. 2011. Low-level laser therapy, at 830 nm, for pain reduction in experimental model of rats with sciatica. Arq Neuropsiquiatr 69: 356-359.
11. Boschi ES, Leite CE, Saciura VC, Caberlon E, Lunardelli A, Bitencourt S, Melo DA, Oliveira JR. 2008. Anti-Inflammatory effects of low-level laser therapy (660 nm) in the early phase in carrageenan-induced pleurisy in rat. Lasers Surg Med 40: 500-508.
12. Byrnes KR, Wu X, Waynant RW, Ilev IK, Anders JJ. 2005. Low power laser irradiation alters gene expression of olfactory ensheathing cells in vitro. Lasers Surg Med 37: 161-171.
13. Chou LW, Wang J, Chang PL, Hsieh YL. 2011. Hyaluronan modulates accumulation of hypoxia-inducible factor-1 alpha, inducible nitric oxide synthase, and matrix metalloproteinase-3 in the synovium of rat adjuvant-induced arthritis model. Arthritis Res Ther 13: R90.
14. Dehne N, Brune B. 2009. HIF-1 in the inflammatory microenvironment. Exp Cell Res 315: 1791-1797.
15. DeLeo JA, Colburn RW, Rickman AJ. 1997. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res 759: 50-57.
16. Elwakil TF, Elazzazi A, Shokeir H. 2007. Treatment of carpal tunnel syndrome by low-level laser versus open carpal tunnel release. Lasers Med Sci 22: 265-270.
17. Ferreira MC, Gameiro J, Nagib PR, Brito VN, Vasconcellos Eda C, Verinaud L. 2009. Effect of low intensity helium-neon (HeNe) laser irradiation on experimental paracoccidioidomycotic wound healing dynamics. Photochem Photobiol 85: 227-233.
18. Fraisl P, Aragones J, Carmeliet P. 2009. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 8: 139-152.
19. Gigo-Benato D, Geuna S, Rochkind S. 2005. Phototherapy for enhancing peripheral nerve repair: a review of the literature. Muscle Nerve 31: 694-701.
20. Gigo-Benato D, Russo TL, Tanaka EH, Assis L, Salvini TF, Parizotto NA. 2010. Effects of 660 and 780 nm low-level laser therapy on neuromuscular recovery after crush injury in rat sciatic nerve. Lasers Surg Med. 42: 673-682.
21. Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W. 2005. Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 25: 297-310.
22. Hobson MI, Green CJ, Terenghi G. 2000. VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J Anat 97: 591-605.
23. Hoke A. 2006. Neuroprotection in the peripheral nervous system: rationale for more effective therapies. Arch Neurol 63: 1681-1685.
24. Hou JF, Zhang H, Yuan X, Li J, Wei YJ, Hu SS. 2008. In vitro effects of low-level laser irradiation for bone marrow mesenchymal stem cells: proliferation, growth factors secretion and myogenic differentiation. Lasers Surg Med 40: 726-733.
25. Kingery WS, Castellote JM, Wang EE. 1993. A loose ligature-induced mononeuropathy produces hyperalgesias mediated by both the injured sciatic nerve and the adjacent saphenous nerve. Pain 55: 297-304.
26. Li F, Fang L, Huang S, Yang Z, Nandi J, Thomas S, Chen C, Camporesi E. 2011. Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropathic pain and reduces tumor necrosis factor-alpha production. Anesth Analg 113: 626-633.
27. Liou JT, Liu FC, Mao CC, Lai YS, Day YJ. 2011. Inflammation confers dual effects on nociceptive processing in chronic neuropathic pain model. Anesthesiology 114: 660-672.
28. Lomb DJ, Desouza LA, Franklin JL, Freeman RS. 2009. Prolyl hydroxylase inhibitors depend on extracellular glucose and hypoxia-inducible factor (HIF)-2alpha to inhibit cell death caused by nerve growth factor (NGF) deprivation: evidence that HIF-2alpha has a role in NGF-promoted survival of sympathetic neurons. Mol Pharmacol 75: 1198-1209.
29. Mace KA, Yu DH, Paydar KZ, Boudreau N, Young DM. 2007. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair. Wound Repair Regen 15: 636-645.
30. Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA. 2001. Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol 169: 386-391.
31. Pereira Lopes FR, Lisboa BC, Frattini F, Almeida FM, Tomaz MA, Matsumoto PK, Langone F, Lora S, Melo PA, Borojevic R, Han SW, Martinez AM. 2011. Enhancement of sciatic-nerve regeneration after VEGF gene therapy. Neuropathol Appl Neurobiol 37: 600-612.
32. Ro LS, Chen ST, Tang LM. 1998. Extent of collateral sprouting of intact nerve fibers in rats depends on the local availability of nerve growth factor. J Formos Med Assoc 97: 247-251.
33. Rochkind S. 2009. Phototherapy in peripheral nerve regeneration: from basic science to clinical study. Neurosurg Focus 26: E8.
34. Rochkind S, Geuna S, Shainberg A. 2009. Chapter 25: Phototherapy in peripheral nerve injury: effects on muscle preservation and nerve regeneration. Int Rev Neurobiol 87: 445-464.
35. Schmitz C, Hof PR. 2005. Design-based stereology in neuroscience. Neuroscience 130: 813-831.
36. Shooshtari SM, Badiee V, Taghizadeh SH, Nematollahi AH, Amanollahi AH, Grami MT. 2008. The effects of low level laser in clinical outcome and neurophysiological results of carpal tunnel syndrome. Electromyogr Clin Neurophysiol 48: 229-231.
37. Sommer C, Kress M. 2004. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 361: 184-187.
38. Sommer C, Schäfers M. 2004. Mechanisms of neuropathic pain: the role of cytokines. Drug Disc Today Dis Mech 1: 441-448.
39. Takeda K, Ichiki T, Narabayashi E, Inanaga K, Miyazaki R, Hashimoto T, Matsuura H, Ikeda J, Miyata T, Sunagawa K. 2009. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced T-alpha expression. Arterioscler Thromb Vasc Biol 29: 2132-2137.
40. Unger JW, Klitzsch T, Pera S, Reiter R. 1998. Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphological investigations of the sural nerve, dorsal root ganglion, and spinal cord. Exp Neurol 153: 23-34.
41. Webber C, Zochodne D. 2010. The nerve regenerative microenvironment: early behavior and partnership of axons and Schwann cells. Exp Neurol 223: 51-59.
42. Xu Z, Fang S, Zuo Y, Zhang Y, Cheng R, Wang Q, Yang Z, Cai W, Ma J, Yang X, Gao G. 2011. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis. Cancer Sci 102: 1789-1798.
43. Zimmermann M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
44. Zimmermann M. 2001. Pathobiology of neuropathic pain. Eur J Pharmacol 429: 23-37.